LONDON, July 12, 2010 /PRNewswire/ -- MRC Technology (UK) announced today that it has entered into an agreement with Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: ...

BEIJING and LONDON, Nov. 21, 2014 (GLOBE NEWSWIRE) -- Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351), a leading pharmaceutical company in China, today announced an exclusive license ...

The U.K.’s MRC Technology medical research charity has changed its name to LifeArc and unveiled plans to set up two seed and research funding initiatives as part of a projected £500 million ...

MRC Technology (MRCT) is pleased to highlight that today the first drug to be approved through the Early Access to Medicine Scheme (EAMS) has been named as pembrolizumab, an immunotherapy treatment ...

Tech transfer organization MRC Technology negotiated a license allowing Bio-Techne to develop reagent products using a protein synthesis technology, Genetically encoded Orthogonal Protection and ...

MARTINSRIED, Germany, March 20, 2007 (PRIME NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) today announced that its business unit AbD Serotec has significantly expanded its ...

MRC Technology announce it is collaborating with Dr Zameel Cader at Oxford University’s Nuffield Department of Clinical Neurosciences, to screen selective and potent potassium channel activators to ...

The work is the first to be funded by the Dementia Consortium - a unique £3m drug discovery collaboration between Alzheimer's Research UK, MRC Technology and the pharmaceutical companies Eisai and ...